2022 update of the drug resistance mutations in HIV-1.
A. Wensing, V. Calvez, F. Ceccherini‐Silberstein, C. Charpentier, H. Günthard, R. Paredes, Robert W Shafer, D. Richman
tlooto Summary
The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antireTroviral therapy.
Abstract
The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.
Citation format
WENSING, A., et al. 2022 update of the drug resistance mutations in HIV-1. Topics in Antiviral Medicine, 2022, 30 4: 559–574.